To evaluate whether SESN3 silencing could suppress SCLC tumor growth in vivo, H446-BR cells infected with shNEG, shSESN3−1 or shSESN3−2 were used to establish model of transplanted subcutaneously tumors in nude mice. This evidence concerns the gene SESN3 and neoplasm.